Archives
-
Eimeria Infection and Cecal Omics in Chickens
2026-09-23
This study paired 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how Eimeria tenella infection and treatment alter the chicken cecal environment. Ethanamizuril was associated with a microbiota profile interpreted as more stable, while sulfachlorpyridazine was associated with reduced Escherichia-Shigella; the low-dose combination had limited effects under the conditions tested. The results show how paired community and metabolite measurements can help characterize treatment response, but do not establish the mechanism behind each change.
-
Ranolazine: Metabolic Context for Ischemia Assays
2026-09-23
Ranolazine is an anti-ischemic agent whose late sodium current inhibition and metabolic effects create a powerful framework for cardiac ischemia research. This article connects myocardial relaxation studies with a rigorous assay-design analysis inspired by HBV–TBK1–autophagy research, while clearly separating established evidence from testable hypotheses.
-
3-Deazaadenosine: Reading m6A Biology
2026-09-22
3-Deazaadenosine is an S-adenosylhomocysteine hydrolase inhibitor that links methylation biochemistry with m6A-centered disease research. This article explains how to use it as a mechanistic perturbation while avoiding overinterpretation in fibrosis, antiviral, and viral infection assays.
-
E-4031 for 3D Cardiac Electrophysiology
2026-09-22
E-4031 provides a potency-centered way to challenge cardiac organoids and quantify hERG-linked repolarization defects in three dimensions. Combined with shell microelectrode arrays, it supports spatially resolved cardiac electrophysiology research, orthogonal calcium validation, and controlled proarrhythmic substrate modeling.
-
Lamotrigine Beyond Seizure Control: A Translational Map
2026-09-21
Lamotrigine is more than a sodium channel probe for epilepsy research. This thought-leadership analysis connects ion-channel pharmacology with serotonin signaling, cardiac translation, and CYP19-related endocrine questions while providing a practical framework for reproducible assay design.
-
PDHA1 Succinylation and α-KGA in Cholangiocarcinoma
2026-09-21
A 2025 Nature Communications study identifies PDHA1 K83 succinylation as a metabolic control point that increases α-KGA accumulation and suppresses macrophage MHC-II antigen presentation through OXGR1–MAPK signaling. The findings connect tumor metabolic reprogramming with immune escape and suggest that inhibiting this axis may improve gemcitabine–cisplatin responses in cholangiocarcinoma.
-
PDHA1 Succinylation, α-KGA, and Cholangiocarcinoma
2026-09-20
A 2025 Nature Communications study identifies PDHA1 lysine 83 succinylation as a metabolic control point that drives alpha-ketoglutarate accumulation and suppresses macrophage MHC-II antigen presentation through OXGR1–MAPK signaling. The findings connect tumor metabolic flux with immune escape and provide a preclinical rationale for combining succinylation-directed intervention with gemcitabine and cisplatin.
-
MDA Assays for Ferroptosis-Driven Drug Resistance
2026-09-19
A translational framework for using malondialdehyde measurement to connect ferroptosis biology, sunitinib resistance, and assay strategy in clear cell renal cell carcinoma.
-
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-09-18
Build sensitive, transient reporter workflows around Cap1-capped and polyadenylated luciferase mRNA for delivery, translation, viability, and imaging studies. This guide connects practical assay design with lipid nanoparticle benchmarking inspired by a renal ischemia-reperfusion study.
-
Quinolone–Coumarin Hybrids Against Toxoplasma gondii
2026-09-18
A 2024 Acta Parasitologica study evaluated 12 quinolone–coumarin hybrids derived from fluoroquinolone antibiotics and novobiocin against Toxoplasma gondii in cell-based assays. QC1, QC3, QC6, and novobiocin showed the most favorable balance between anti-parasitic activity and host-cell safety, providing a rationale for further lead optimization rather than immediate therapeutic use.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-17
Zhao and colleagues present a standardized fresh whole-blood platform for testing how metabolic interventions reshape stimulus-specific immune responses. The protocol links controlled pattern-recognition or microbial stimulation with pathway-directed inhibition and cytokine quantification, supporting more reproducible immunometabolism and cohort studies.
-
TCAIM Regulation of OGDH in Mitochondrial Metabolism
2026-09-17
The 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and lowers its protein abundance through HSPA9 and LONP1. By connecting mitochondrial proteostasis with control of a rate-limiting TCA-cycle enzyme, the work reveals a post-translational mechanism that suppresses OGDH complex activity and reshapes carbohydrate metabolism.
-
FCCP: From Bioenergetic Stress to Translational Insight
2026-09-16
FCCP is more than an oxidative phosphorylation uncoupler. By linking mitochondrial proton-gradient dissipation with HIF signaling, cancer metabolism, and the newly described CO2-dependent communication between axons and Schwann cells, this article outlines how translational researchers can use FCCP to build more informative mechanistic experiments.
-
TCAIM, OGDH Proteolysis, and Mitochondrial Metabolism
2026-09-16
The reference study identifies TCAIM as a DNAJC co-chaperone that selectively binds the OGDH subunit of the α-ketoglutarate dehydrogenase complex and promotes its mtHSP70- and LONP1-dependent degradation. Its structural, cellular, and mouse data support a model in which mitochondrial proteostasis directly adjusts metabolic enzyme abundance, activity, and bioenergetic state.
-
Ranolazine: Mechanism and Research Workflow
2026-09-15
Ranolazine is an anti-ischemic agent that primarily inhibits the cardiac late sodium current and limits sodium-dependent calcium overload. Its metabolic profile also supports glucose oxidation enhancement and experimental studies of fatty acid oxidation, myocardial relaxation, and cardiac ischemia.